These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29059242)

  • 1. Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant.
    Sun X; Chen W; He L; Sheng J; Liu Y; Vu GP; Yang Z; Li W; Trang P; Wang Y; Hai R; Zhu H; Lu S; Liu F
    PLoS One; 2017; 12(10):e0186791. PubMed ID: 29059242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells.
    Zou H; Lee J; Umamoto S; Kilani AF; Kim J; Trang P; Zhou T; Liu F
    J Biol Chem; 2003 Sep; 278(39):37265-74. PubMed ID: 12867424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
    Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
    J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
    Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins.
    Yang Z; Reeves M; Ye J; Trang P; Zhu L; Sheng J; Wang Y; Zen K; Wu J; Liu F
    Viruses; 2015 Jun; 7(7):3345-60. PubMed ID: 26114473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.
    Li W; Liu Y; Wang Y; Li R; Trang P; Tang W; Yang Z; Wang Y; Sun X; Xing X; Lu S; Liu F
    Theranostics; 2018; 8(20):5634-5644. PubMed ID: 30555569
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
    Trang P; Kim K; Zhu J; Liu F
    J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Amplification and Selection of Engineered RNase P Ribozyme for Gene Targeting Applications.
    Trang P; Zhang I; Liu F
    Methods Mol Biol; 2024; 2822():419-429. PubMed ID: 38907932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered RNase P ribozymes effectively inhibit human cytomegalovirus gene expression and replication.
    Yang Z; Vu GP; Qian H; Chen YC; Wang Y; Reeves M; Zen K; Liu F
    Viruses; 2014 Jun; 6(6):2376-91. PubMed ID: 24932966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered external guide sequences are highly effective in inducing RNase P for inhibition of gene expression and replication of human cytomegalovirus.
    Yang YH; Li H; Zhou T; Kim K; Liu F
    Nucleic Acids Res; 2006; 34(2):575-83. PubMed ID: 16432261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection.
    Smith A; Zhang I; Trang P; Liu F
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.
    Kim K; Trang P; Umamoto S; Hai R; Liu F
    Nucleic Acids Res; 2004; 32(11):3427-34. PubMed ID: 15220469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus.
    Kim K; Umamoto S; Trang P; Hai R; Liu F
    RNA; 2004 Mar; 10(3):438-47. PubMed ID: 14970389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNase P ribozyme as an antiviral agent against human cytomegalovirus.
    Trang P; Liu F
    Methods Mol Biol; 2004; 252():437-50. PubMed ID: 15017069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.
    Adamson CS; Nevels MM
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31963209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme.
    Zeng W; Chen YC; Bai Y; Trang P; Vu GP; Lu S; Wu J; Liu F
    PLoS One; 2012; 7(12):e51855. PubMed ID: 23300569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA.
    Bai Y; Trang P; Li H; Kim K; Zhou T; Liu F
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10919-24. PubMed ID: 18663226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA.
    Zou H; Lee J; Kilani AF; Kim K; Trang P; Kim J; Liu F
    J Biol Chem; 2004 Jul; 279(31):32063-70. PubMed ID: 15169770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.